Skip to main content
placeholder image

PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine + nab-paclitaxel (GNP) chemotherapies.

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2019

Citation


  • Ross, P. J., Croagh, D., Aghmesheh, M., Nagrial, A., Nguyen, N., Nikfarjam, M., . . . Harris, M. (2019). PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine + nab-paclitaxel (GNP) chemotherapies.. Journal of Clinical Oncology, 37(15_suppl), 4125. doi:10.1200/jco.2019.37.15_suppl.4125

Web Of Science Accession Number


Start Page


  • 4125

End Page


  • 4125

Volume


  • 37

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2019

Citation


  • Ross, P. J., Croagh, D., Aghmesheh, M., Nagrial, A., Nguyen, N., Nikfarjam, M., . . . Harris, M. (2019). PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine + nab-paclitaxel (GNP) chemotherapies.. Journal of Clinical Oncology, 37(15_suppl), 4125. doi:10.1200/jco.2019.37.15_suppl.4125

Web Of Science Accession Number


Start Page


  • 4125

End Page


  • 4125

Volume


  • 37

Issue


  • 15_suppl

Place Of Publication